GlassScriptPhysician profile
James D Rossen
NPI 1134100514
$5,218.97
in general payments reported to CMS, 2019-2025
17 companies · $841 in 2025
The $841 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $732 · 2021: $471 · 2022: $301 · 2023: $494 · 2024: $2,064 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,683 · Travel and Lodging: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,683.31 |
| Travel and Lodging | $715.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,520.90 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $1,060.26 | 2021-2025 | Accolade Sr, Watchman Flx, Farapulse |
| Medtronic Vascular, INC. | $680.76 | 2020 | |
| Inari Medical, INC. | $579.54 | 2020-2022 | |
| Abiomed | $303.50 | 2019-2025 | Impella |
| Medtronic, INC. | $285.15 | 2021-2025 | Corevalve Evolut R |
| Philips North America LLC | $253.37 | 2019-2024 | (P77) Azurion 7 M20 |
| Abbott Laboratories | $163.35 | 2021-2025 | Aveir, Portico, Assurity |
| Shockwave Medical, INC | $126.13 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $72.68 | 2023-2024 | |
| Cardiva Medical, INC. | $48.70 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Getinge USA Sales, LLC | $35.82 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $25.30 | 2024 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.76 | 2025 | Lifevest |
| Bard Peripheral Vascular, INC. | $16.12 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $14.25 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rossen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.